SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • September 8th, 2023 • Cellectar Biosciences, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledSeptember 8th, 2023 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of September 5, 2023, by and among Cellectar Biosciences, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).